Shoreline Biosciences and BeiGene collaborate on genetically modified natural killer cell therapies
Shoreline Biosciences and BeiGene have announced an exclusive worldwide strategic collaboration to develop and commercialize a portfolio of natural killer (NK) based cell therapeutics.